Maureen Watt

Dec 3, 2024 | healio.com | Richard Gawel |Kristen Dowd |Maureen Watt

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Median time between initiation of lanadelumab treatment and first reduction was 6.5 months. Researchers said that down-titration may be considered with well-controlled symptoms.

Feb 3, 2023 | jacionline.org | Maureen Watt |Marcus Maurer |Pharmacology ITMP |William Lumry

Berotralstat Improved Quality of Life through 96 Weeks Across Multiple Subgroups of Patients with Hereditary Angioedema